查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1655515

体外二氧化碳去除装置的全球市场

Extracorporeal CO2 Removal Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计 2030 年全球体外二氧化碳去除装置市场规模将达 1.519 亿美元

2024 年全球体外二氧化碳移除装置市场规模估计为 1.073 亿美元，预计到 2030 年将达到 1.519 亿美元，2024-2030 年分析期间内的复合年增长率为 6.0%。体外二氧化碳设备是报告中分析的细分市场之一，预计到分析期结束时复合年增长率为 6.6%，达到 8,990 万美元。在分析期间内，抛弃式部分的复合年增长率预计为 5.4%。

美国市场规模估计为 2,940 万美元，中国市场预估年复合成长率为 5.5%

预计 2024 年美国体外二氧化碳去除装置市值将达 2,940 万美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 2,360 万美元，2024-2030 年分析期间的复合年增长率为 5.5%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 5.1% 和 5.1%。在欧洲，德国的复合年增长率预计为 4.5%。

全球体外二氧化碳去除设备市场 - 主要趋势与驱动因素摘要

为什么体外二氧化碳去除装置对于呼吸照护至关重要？

体外二氧化碳移除（ECCO2R）装置透过提供传统机械通气的微创替代方案，已成为严重呼吸系统疾病管理的必需品。 ECCO2R 设备的工作原理是从患者血液中外部去除二氧化碳 (CO2)，为患有慢性阻塞性肺病(COPD)、急性呼吸窘迫症候群(ARDS) 和其他肺部疾病且二氧化碳积聚是一个严重问题的患者提供缓解。这些设备对于治疗严重病例特别有益，无需高压机械通气，因为高压机械通气可能会导致进一步的肺部损伤。透过降低二氧化碳水平，ECCO2R 设备可以稳定呼吸功能，让肺部休息和恢復。便携式、易于使用版本的开发也扩大了其在加护病房之外的用途，使其成为慢性呼吸道管理的一种有前途的解决方案。

技术进步如何影响 ECCO2R 市场？

医疗技术的不断进步使得 ECCO2R 设备更有效率、更紧凑，能够适应不同患者的需求。创新包括整合生物相容性材料以最大限度地减少併发症和感染，以及使用先进的监测系统来确保根据每位患者的具体情况精确去除二氧化碳。医疗保健领域微创方法的趋势也导致了侵入性较小的 ECCO2R 设备的设计，从而可以更快地进行设定并更容易地整合到现有的呼吸支持系统中。此外，各公司正致力于开发可灵活适应医院和居家照护环境的可携式设备，为慢性病管理的新途径铺路。这些进步使 ECCO2R 设备成为呼吸系统疾病管理的重要组成部分，改善了患者的治疗效果，同时降低了医疗成本。

ECCO2R设备有哪些新的应用与趋势？

ECCO2R 设备的市场正在超越传统的医院环境。随着全球慢性呼吸系统疾病的增加，ECCO2R 设备越来越多地被视为长期管理解决方案，尤其是在门诊病人和居家医疗环境中。在重症加护环境中，传统方法无效或有併发症风险的医疗保健专业人员越来越多地采用 ECCO2R 设备。此外，COVID-19 疫情凸显了对有效呼吸支援设备的需求，刺激了研究和开发工作，以提高 ECCO2R 的效率和可及性。对病患移动性和舒适度的日益关注也促使製造商进行创新，生产更轻、用途更广泛的设备，可用于各种护理环境，包括紧急应变单位和野战医院。

哪些因素推动了 ECCO2R 市场的成长？

ECCO2R 市场的成长受到多种因素的推动，包括 COPD 和 ARDS 等呼吸系统疾病的盛行率不断上升，这些疾病需要有效的二氧化碳管理解决方案。 COVID-19 疫情的影响也凸显了对先进呼吸支援技术的需求，进一步刺激了需求。此外，高度生物相容性和微创 ECCO2R 设备的开发等技术创新正在促进这些系统在各种医疗保健环境中的采用。在患者偏好和降低医疗成本的需求的推动下，携带式和居家照护呼吸解决方案的发展进一步推动了市场的成长。医疗保健基础设施和呼吸设备技术创新的投资不断增加，尤其是在新兴市场，预计将为 ECCO2R 领域提供巨大的成长机会。

部分

产品（体外二氧化碳机器、抛弃式、其他产品）；通路（静脉、动静脉）；应用（肺移植桥接、急性呼吸窘迫症候群(ARDS)、慢性阻塞性肺病(COPD)、其他应用）；最终用途（医院、门诊手术中心、诊所、其他最终用途）

受访公司范例（44家值得关注的公司）

  • Aferetica Srl
  • Alung Technologies, Inc.
  • ESTOR SPA
  • Getinge AB
  • Medica SpA
  • Medtronic PLC
  • Xenios AG

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP16374

Global Extracorporeal CO2 Removal Devices Market to Reach US$151.9 Million by 2030

The global market for Extracorporeal CO2 Removal Devices estimated at US$107.3 Million in the year 2024, is expected to reach US$151.9 Million by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Extracorporeal CO2 Machines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$89.9 Million by the end of the analysis period. Growth in the Disposables segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$29.4 Million While China is Forecast to Grow at 5.5% CAGR

The Extracorporeal CO2 Removal Devices market in the U.S. is estimated at US$29.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$23.6 Million by the year 2030 trailing a CAGR of 5.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.1% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Extracorporeal CO2 Removal Devices Market - Key Trends & Drivers Summarized

Why Are Extracorporeal CO2 Removal Devices Critical for Respiratory Care?

Extracorporeal CO2 removal (ECCO2R) devices have become vital in the management of severe respiratory conditions, offering a less invasive alternative to traditional ventilation. ECCO2R devices function by removing carbon dioxide (CO2) from the patient’s blood externally, providing relief for patients with chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and other lung disorders where CO2 accumulation is a critical concern. These devices are particularly beneficial in managing severe cases without the need for high-pressure mechanical ventilation, which can cause further lung injury. By reducing CO2 levels, ECCO2R devices help stabilize respiratory functions, allowing the lungs to rest and recover. The development of portable and user-friendly versions of these devices is also expanding their use beyond intensive care units, making them a promising solution for chronic respiratory management.

How Are Technological Advancements Shaping the ECCO2R Market?

With continuous advancements in medical technology, ECCO2R devices are becoming more efficient, compact, and adaptable to various patient needs. Innovations include integrating biocompatible materials that minimize complications and infections, and the use of advanced monitoring systems that ensure precise CO2 removal tailored to each patient’s specific condition. The trend toward minimally invasive approaches in healthcare has also led to the design of ECCO2R devices that are less intrusive, enabling quicker setup and easier integration into existing respiratory support systems. Additionally, companies are focusing on developing portable devices that offer greater flexibility for both in-hospital and home care settings, opening new avenues for chronic condition management. These advancements are making ECCO2R devices a pivotal component in the management of respiratory diseases, enhancing patient outcomes while reducing healthcare costs.

What Are the Emerging Applications and Trends in ECCO2R Devices?

The market for ECCO2R devices is expanding as their applications extend beyond traditional hospital settings. With increasing incidences of chronic respiratory diseases globally, these devices are now being explored for long-term management solutions, especially in outpatient and home-care environments. Medical practitioners are increasingly adopting ECCO2R devices for critical care scenarios where traditional methods might be ineffective or pose risks of complications. Furthermore, the COVID-19 pandemic has highlighted the need for effective respiratory support devices, boosting the research and development efforts towards improving ECCO2R efficiency and accessibility. The growing emphasis on patient mobility and comfort is also pushing manufacturers to innovate, producing lighter and more versatile devices that can be used in diverse care settings, including emergency response units and field hospitals.

What Factors Are Fueling the Growth of the ECCO2R Market?

The growth in the ECCO2R market is driven by several factors, including the increasing prevalence of respiratory diseases such as COPD and ARDS, which demand effective CO2 management solutions. The impact of the COVID-19 pandemic has also underscored the necessity for advanced respiratory support technologies, further stimulating demand. Additionally, technological innovations, such as the development of biocompatible and minimally invasive ECCO2R devices, are enhancing the adoption of these systems in various healthcare settings. The push towards portable and home-care respiratory solutions, fueled by patient preference and the need for healthcare cost reduction, is further accelerating the market’s growth. Rising investments in healthcare infrastructure and respiratory device innovation, particularly in emerging markets, are expected to create significant growth opportunities in the ECCO2R sector.

SCOPE OF STUDY:

The report analyzes the Extracorporeal CO2 Removal Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Extracorporeal CO2 Machines, Disposables, Other Products); Access (Venovenous, Arteriovenous); Application (Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD), Other Applications); End-Use (Hospitals, Ambulatory Surgery Centers, Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Aferetica Srl
  • Alung Technologies, Inc.
  • ESTOR S.P.A
  • Getinge AB
  • Medica SpA
  • Medtronic PLC
  • Xenios AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Extracorporeal CO2 Removal Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Respiratory Disorders Fueling Demand for CO2 Removal
    • Growing Adoption of Minimally Invasive Respiratory Support Technologies
    • Expansion of Intensive Care Units and Demand for Advanced Respiratory Equipment
    • Increasing Focus on Reducing Ventilator Dependency in Critical Care
    • Technological Advancements in Extracorporeal Life Support Systems
    • Rising Demand for Portable and User-Friendly CO2 Removal Devices
    • Growth in Awareness of Lung Preservation and Respiratory Support Options
    • Increased Research and Development for Efficient Gas Exchange Technologies
    • Growing Investment in Respiratory Care in Hospitals and Clinics
    • Surge in Use of CO2 Removal in Emergency and Acute Care Settings
    • Expansion of Extracorporeal Therapies in Cardiopulmonary Rehabilitation
    • Rising Demand for CO2 Removal in Pediatric and Neonatal Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Extracorporeal CO2 Removal Devices Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Extracorporeal CO2 Removal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Extracorporeal CO2 Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Extracorporeal CO2 Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Extracorporeal CO2 Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Extracorporeal CO2 Machines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Disposables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Venovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Venovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Venovenous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Arteriovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Arteriovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Arteriovenous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Bridge To Lung Transplant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Bridge To Lung Transplant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Bridge To Lung Transplant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Acute Respiratory Distress Syndrome (ARDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Acute Respiratory Distress Syndrome (ARDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Acute Respiratory Distress Syndrome (ARDS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Japan 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 80: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: China 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Extracorporeal CO2 Removal Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 107: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: France 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Germany 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Italy 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 143: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: UK 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 152: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: UK 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Asia-Pacific 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Asia-Pacific 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: Asia-Pacific 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: Asia-Pacific 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 179: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of World 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of World 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of World 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of World 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION